Clinical outcomes of WBRT plus EGFR-TKIs versus WBRT or TKIs alone for the treatment of cerebral metastatic NSCLC patients: a meta-analysis

Whether WBRT plus EGFR-TKIs has a greater survival benefit than EGFR-TKIs alone or WBRT alone remains controversial in NSCLC patients with multiple brain metastases. To rectify this, we conducted a systematic meta-analysis based on 9 retrospective studies and 1 randomized controlled study published...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hong, Liu, Quan-Xing, Hou, Bin, Zhou, Dong, Li, Jing-Meng, Lu, Xiao, Wu, Qiu-Ping, Dai, Ji-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593647/
https://www.ncbi.nlm.nih.gov/pubmed/28915676
http://dx.doi.org/10.18632/oncotarget.19054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593647/
https://www.ncbi.nlm.nih.gov/pubmed/28915676
http://dx.doi.org/10.18632/oncotarget.19054

Ejemplares similares